2m 2m 2m 2m 2m 2m 2m
AMNEAL PHRMCTL-A (AMRX)
NASDAQ
$17.08+$0.07 (+0.42%)
Price as of Sep 11, 2026 7:55 PM EDT- $5.9BMarket Cap
- 70.10%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AMNEAL PHRMCTL-A (AMRX)
$17.08+$0.07 (+0.42%)
AMRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.01 | ||
Change | +$0.14 (+0.83%) | ||
Open | $17.00 | ||
High | $17.11 | ||
Low | $16.73 | ||
Previous Close | $16.87 | ||
Volume | 1,186,111 | ||
30-Day Average Volume | 1,697,273 | ||
1-Week Change | -2.47% | ||
1-Month Change | -0.53% | ||
1-Year Change | 70.10% | ||
3-Year Change | 342.97% | ||
5-Year Change | 232.23% | ||
Fundamentals | |||
Shares Outstanding | 348.3M | ||
Total Assets | $3.8B | ||
Market Cap | $5.9B | ||
Enterprise Value | $8.5B | ||
Period: QTR TTM FY | |||
Revenue | $796.2M | ||
Net Income | $57.7M | ||
Free Cash Flow | -$51.9M | ||
EBIT | $114.1M | ||
EBITDA | $149.0M | ||
Net Working Capital | $1.1B | ||
EPS | $0.18 | ||
Enterprise Value/EBITDA | 57 | ||
Enterprise Value/Revenue | 11 | ||
P/B | 179 | ||
P/E | 95 | ||
PEG | -18 | ||
Price/Free Cash Flow | -114 | ||
Price/Operating Cash Flow | -279 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 08/26/2013 | ||
Earnings & Revenue